{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:54:06Z","timestamp":1781549646543,"version":"3.54.5"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Multidrug-resistant (MDR) and rifampin-resistant (RR) tuberculosis (TB) is challenging the national response to tuberculosis in Namibia. The recent introduction of Xpert MTB\/RIF (Cepheid, Sunnyvale, CA) and the use of new and repurposed drugs have the potential to improve both management and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Retrospective review of Namibian national registry data from 2013 to 2023 of children 0\u201314 years with MDR\/RR-TB. National census data were used to estimate annual case notification rates (aCNRs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Totally 205 episodes were available for analysis. The median age was 4 years [interquartile range (IQR) 1\u201310]. Ninety (43.9%) were female and 20 (9.8%) were living with HIV. The aCNR increased by two-thirds from 1.2 in 2013 to 2.0 per 100,000 population in 2023. One region, Ojotzondjupa, notified 58 (28.3%) of all cases with a median aCNR of 7.1 per 100,000 population while the national median aCNR was 1.8 per 100,000 population. Ninety individuals (58.1%) received a treatment regimen containing injectables, whereas 65 (41.9.6%) received an all-oral treatment regimen containing two or more World Health Organization class A drugs and\/or delamanid. Outcome was unfavorable in 46 (24.1%) individuals, and 18 (9.4%) died. No decrease in the proportion of children with unfavorable outcomes was observed over the study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The epidemiology and outcome of children with MDR\/RR-TB in Namibia are in keeping with the limited international data available; however, the geographical distribution of children with MDR\/RR-TB poses a major challenge to the national TB response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004933","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T19:00:20Z","timestamp":1755630020000},"page":"1159-1165","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology and Outcomes of Pediatric Multidrug-resistant Tuberculosis in Namibia: A Retrospective Review of National Registry Data From 2013 to 2023"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1892-0601","authenticated-orcid":false,"given":"Ingrid","family":"Burkhardt","sequence":"first","affiliation":[{"name":"Division of Paediatric Infectious Diseases, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1764-3574","authenticated-orcid":false,"given":"Nunurai","family":"Ruswa","sequence":"additional","affiliation":[{"name":"National Tuberculosis and Leprosy Programme, Ministry of Health and Social Services, Windhoek, Namibia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Iitana","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Katutura Intermediate Hospital, Ministry of Health and Social Services, Windhoek, Namibia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilya","family":"Ekandjo","sequence":"additional","affiliation":[{"name":"Department of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5927-284X","authenticated-orcid":false,"given":"Mareli M.","family":"Claassens","sequence":"additional","affiliation":[{"name":"Department of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4302-5606","authenticated-orcid":false,"given":"Emmanuel","family":"Nepolo","sequence":"additional","affiliation":[{"name":"Department of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3554-7949","authenticated-orcid":false,"given":"Christoph","family":"Aebi","sequence":"additional","affiliation":[{"name":"Division of Paediatric Infectious Diseases, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2296-2302","authenticated-orcid":false,"given":"James A.","family":"Seddon","sequence":"additional","affiliation":[{"name":"Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa"},{"name":"Department of Infectious Disease, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2217-4322","authenticated-orcid":false,"given":"Gunar","family":"G\u00fcnther","sequence":"additional","affiliation":[{"name":"Department of Human, Biological and Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia"},{"name":"Department of Pulmonology, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"R1-20260615","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1473-3099(16)30132-3","article-title":"Global burden of drug-resistant tuberculosis in children: a mathematical modelling study.","volume":"16","author":"Dodd","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R2-20260615","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(14)60195-1","article-title":"Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates.","volume":"383","author":"Jenkins","year":"2014","journal-title":"Lancet (London, England)"},{"key":"R3-20260615","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S2352-4642(24)00330-4","article-title":"Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis.","volume":"9","author":"Garcia-Prats","year":"2025","journal-title":"Lancet Child Adolesc Health"},{"key":"R5-20260615","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1016\/S1473-3099(24)00144-0","article-title":"The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis\u2014lessons from the South African experience.","volume":"24","author":"Naidoo","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"R11-20260615","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/S2214-109X(24)00383-8","article-title":"Global burden of tuberculous meningitis in children aged 0\u201314 years in 2019: a mathematical modelling study.","volume":"13","author":"Du Preez","year":"2025","journal-title":"Lancet Glob Health"},{"key":"R12-20260615","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5588\/ijtld.15.0471","article-title":"Counting children with tuberculosis: why numbers matter.","volume":"19","author":"Seddon","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"R15-20260615","doi-asserted-by":"crossref","first-page":"e0158622","DOI":"10.1128\/spectrum.01586-22","article-title":"Whole-genome sequencing for resistance prediction and transmission analysis of mycobacterium tuberculosis complex strains from Namibia.","volume":"10","author":"Claassens","year":"2022","journal-title":"Microbiol Spectr"},{"key":"R16-20260615","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1473-3099(23)00498-X","article-title":"Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB\/RIF in Mozambique: a retrospective observational study.","volume":"24","author":"Barilar","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"R17-20260615","doi-asserted-by":"crossref","first-page":"2100621","DOI":"10.1183\/13993003.00621-2021","article-title":"Emergence of bedaquiline resistance in a high tuberculosis burden country.","volume":"59","author":"Chesov","year":"2022","journal-title":"Eur Respir J"},{"key":"R18-20260615","doi-asserted-by":"crossref","first-page":"e972","DOI":"10.1016\/S2666-5247(23)00172-6","article-title":"Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study.","volume":"4","author":"Derendinger","year":"2023","journal-title":"Lancet Microbe"},{"key":"R19-20260615","doi-asserted-by":"crossref","first-page":"1204064","DOI":"10.3389\/fpubh.2023.1204064","article-title":"Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings: a programmatic model, challenges, and initial outcomes.","volume":"11","author":"de Araujo","year":"2023","journal-title":"Front Public Health"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:01:58Z","timestamp":1781546518000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004933","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]}}}